Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Comparative Neurology|September 19, 2012
The cellular and synaptic location of activated TrkB in mouse hippocampus during limbic epileptogenesisJeffrey Helgager, Gumei Liu, James O McNamara
Epilepsia|June 7, 2014
Antiseizure effects of TrkB kinase inhibitionGumei Liu, Robert J Kotloski, James O McNamara
The Journal of Allergy and Clinical Immunology|August 4, 2012
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseasesRobert Fiorentino, Gumei Liu, Anne R Pariser, et al.
Epilepsy Research|September 18, 2012
Conditional deletion of TrkC does not modify limbic epileptogenesisA Soren Leonard, Ram S Puranam, Jeffrey Helgager, et al.
Neurobiology of Disease|February 5, 2013
Altered Purkinje cell miRNA expression and SCA1 pathogenesisEdgardo Rodriguez-Lebron, Gumei Liu, Megan Keiser, et al.
Orphanet Journal of Rare Diseases|September 5, 2020
FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product developmentKathleen L Miller, Christine Mueller, Gumei Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 14, 2005
Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectorsGumei Liu, Inês Martins, John A Wemmie, et al.
Orphanet Journal of Rare Diseases|February 25, 2024
Analysis of the first ten years of FDA's rare pediatric disease priority review voucher program: designations, diseases, and drug developmentCatherine Mease, Kathleen L Miller, Lewis J Fermaglich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNSGumei Liu, Yong Hong Chen, Xiaohua He, et al.
Pageof 1